ATE213279T1 - Diagnoseverfahren und vorrichtung zum nachweis der prädisposition zu bestimmten krankheitszuständen, insbesondere osteoporose, auf basis von il-6 genpolymorphismus - Google Patents
Diagnoseverfahren und vorrichtung zum nachweis der prädisposition zu bestimmten krankheitszuständen, insbesondere osteoporose, auf basis von il-6 genpolymorphismusInfo
- Publication number
- ATE213279T1 ATE213279T1 AT97923169T AT97923169T ATE213279T1 AT E213279 T1 ATE213279 T1 AT E213279T1 AT 97923169 T AT97923169 T AT 97923169T AT 97923169 T AT97923169 T AT 97923169T AT E213279 T1 ATE213279 T1 AT E213279T1
- Authority
- AT
- Austria
- Prior art keywords
- gene
- certain disease
- prediposition
- detecting
- diagnostic method
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Application Of Or Painting With Fluid Materials (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9610281.9A GB9610281D0 (en) | 1996-05-16 | 1996-05-16 | Diagnostic method and apparatus |
PCT/GB1997/001337 WO1997043446A2 (en) | 1996-05-16 | 1997-05-16 | Diagnostic method and apparatus for detecting a predisposition to certain disease states, especially osteoporosis, based on polymorphism in an il-6 gene |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE213279T1 true ATE213279T1 (de) | 2002-02-15 |
Family
ID=10793830
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97923169T ATE213279T1 (de) | 1996-05-16 | 1997-05-16 | Diagnoseverfahren und vorrichtung zum nachweis der prädisposition zu bestimmten krankheitszuständen, insbesondere osteoporose, auf basis von il-6 genpolymorphismus |
Country Status (10)
Country | Link |
---|---|
US (1) | US6066450A (de) |
EP (1) | EP0912759B1 (de) |
JP (1) | JP2000511413A (de) |
AT (1) | ATE213279T1 (de) |
AU (1) | AU727077B2 (de) |
CA (1) | CA2254901A1 (de) |
DE (1) | DE69710469D1 (de) |
GB (1) | GB9610281D0 (de) |
NZ (1) | NZ332702A (de) |
WO (1) | WO1997043446A2 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9610281D0 (en) * | 1996-05-16 | 1996-07-24 | Ralston Stuart H | Diagnostic method and apparatus |
GB9711040D0 (en) * | 1997-05-29 | 1997-07-23 | Duff Gordon W | Prediction of inflammatory disease |
WO1999011822A1 (en) * | 1997-09-03 | 1999-03-11 | Gene Logic Inc. | Method for predicting prognosis and treatment response for genetically based abnormalities |
AUPP547398A0 (en) * | 1998-08-26 | 1998-09-17 | Medvet Science Pty. Ltd. | Predictive assessment of certain skeletal disorders |
JP3709332B2 (ja) * | 2000-09-14 | 2005-10-26 | 株式会社エーシーバイオテクノロジーズ | 骨粗鬆症の診断および/または骨粗鬆症骨折リスクの予測の方法 |
US20030129607A1 (en) * | 2001-05-25 | 2003-07-10 | Invitrogen Corporation | Compositions and methods for extension of nucleic acids |
GB2381526A (en) * | 2001-11-03 | 2003-05-07 | Sequenom Inc | Detection of predisposition to osteoporosis |
US20030198316A1 (en) * | 2002-04-17 | 2003-10-23 | Piet Dewaele | Osteoporosis screening method |
JP2014036581A (ja) * | 2012-08-10 | 2014-02-27 | Nippon Medical School | インターロイキン−6遺伝子プロモーターの多型に基づくケロイド発症可能性の測定 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUT52962A (en) * | 1988-03-04 | 1990-09-28 | Sandoz Ag | Process for production of medical compositions eliminating bone-absorption and promoting forming of bones |
JPH0539299A (ja) * | 1991-05-31 | 1993-02-19 | Sumitomo Metal Ind Ltd | 新規なカルシトニン |
DE69333659T2 (de) * | 1992-07-31 | 2005-11-17 | Garvan Institute Of Medical Research, Darlinghurst | Einschätzung von in trans-agierenden faktoren der allelen variation |
US5436258A (en) * | 1992-09-09 | 1995-07-25 | Eli Lilly And Company | Prevention of bone resorption |
US5402781A (en) * | 1993-03-03 | 1995-04-04 | Washington University | Method and apparatus for determining bone density and diagnosing osteoporosis |
US5441964A (en) * | 1993-10-15 | 1995-08-15 | Eli Lilly And Company | Methods for inhibiting bone loss using substituted benzothiophene |
JPH0925293A (ja) * | 1995-02-14 | 1997-01-28 | Teijin Ltd | ヒスチジル−ヒドロキサム酸誘導体 |
JPH0912592A (ja) * | 1995-06-26 | 1997-01-14 | Taisho Pharmaceut Co Ltd | リグナン系化合物 |
WO1997003060A1 (fr) * | 1995-07-13 | 1997-01-30 | Senju Pharmaceutical Co., Ltd. | Derives de la piperazine et leurs utilisations |
JPH0930977A (ja) * | 1995-07-20 | 1997-02-04 | Tsuneo Nanba | 升麻抽出物を含有する骨疾患治療剤 |
WO1997004799A1 (fr) * | 1995-07-25 | 1997-02-13 | Toray Industries, Inc. | Remede contre les maladies osseuses |
ZA966489B (en) * | 1995-08-03 | 1997-02-26 | Bioph Biotech Entw Pharm Gmbh | New protein human MP52 Arg. |
GB9610281D0 (en) * | 1996-05-16 | 1996-07-24 | Ralston Stuart H | Diagnostic method and apparatus |
-
1996
- 1996-05-16 GB GBGB9610281.9A patent/GB9610281D0/en active Pending
-
1997
- 1997-05-16 DE DE69710469T patent/DE69710469D1/de not_active Expired - Lifetime
- 1997-05-16 AT AT97923169T patent/ATE213279T1/de active
- 1997-05-16 EP EP97923169A patent/EP0912759B1/de not_active Expired - Lifetime
- 1997-05-16 WO PCT/GB1997/001337 patent/WO1997043446A2/en active IP Right Grant
- 1997-05-16 US US08/857,464 patent/US6066450A/en not_active Expired - Lifetime
- 1997-05-16 NZ NZ332702A patent/NZ332702A/xx not_active IP Right Cessation
- 1997-05-16 JP JP09540674A patent/JP2000511413A/ja not_active Ceased
- 1997-05-16 AU AU29041/97A patent/AU727077B2/en not_active Ceased
- 1997-05-16 CA CA002254901A patent/CA2254901A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE69710469D1 (de) | 2002-03-21 |
CA2254901A1 (en) | 1997-11-20 |
WO1997043446A2 (en) | 1997-11-20 |
EP0912759A2 (de) | 1999-05-06 |
AU727077B2 (en) | 2000-11-30 |
EP0912759B1 (de) | 2002-02-13 |
WO1997043446A3 (en) | 1998-01-08 |
AU2904197A (en) | 1997-12-05 |
NZ332702A (en) | 2000-04-28 |
US6066450A (en) | 2000-05-23 |
GB9610281D0 (en) | 1996-07-24 |
JP2000511413A (ja) | 2000-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LIU et al. | Denaturing HPLC-identified novel FBN1 mutations, polymorphisms, and sequence variants in Marfan syndrome and related connective tissue disorders | |
ATE291583T1 (de) | Polymorphismus von mononukleotiden und ihre verwendung in der genanalyse | |
Ceriotti et al. | Single nucleotide polymorphisms in the ovine casein genes detected by polymerase chain reaction-single strand conformation polymorphism | |
DE69029018D1 (de) | Verfahren zum Nachweis von benachbarten und entfernt lokalisierten Allelen als Haplotypen mittels Intronsequenzanalyse | |
DE3381518D1 (de) | Verfahren zur charakterisierung von hla und die darin benutzten cdns-testmittel. | |
DK0950113T3 (da) | Detektion af genetisk prædisposition for synstruende diabetisk retinopati | |
NO972006D0 (no) | Ny metode for diagnose av sykdommer | |
WO2003089897A3 (en) | Diagnosis and treatment of vascular disease | |
ATE194391T1 (de) | Amplifikationsoligonukleotide und sonden für borrelia, die mit lyme kranheit assoziiert sind | |
ATE213279T1 (de) | Diagnoseverfahren und vorrichtung zum nachweis der prädisposition zu bestimmten krankheitszuständen, insbesondere osteoporose, auf basis von il-6 genpolymorphismus | |
DE69704031D1 (de) | Test zur diagnose eines erhöhten brustkrebs-risikos | |
DE60014350D1 (de) | Verfahren zur erkennung und/oder analyse, unter verwendung von primertechniken, von einfachen nukleotidpolymorphismen in restriktionsfragmenten speziell aus amplifizierten restriktionsfragmenten generiert durch aflp | |
ATE203766T1 (de) | Teil der intronsequenz des von hippel-lindau(vhl)-gens und seine verwendung zur krankheitsdiagnose | |
ATE235560T1 (de) | Diagnostisches verfahren basierend auf der quantifizierung extramitochondrialer dna | |
DE69728044D1 (de) | Diagnostisches verfahren und gerät | |
DE69938837D1 (de) | Genomische und vollständige cdna sequenzen von menschlichem adipozyten spezifischem apm1 und biallelische marker davon | |
ATE449868T1 (de) | Methoden, testsätze und kompositionen zur detektion und quantifizierung von zielsequenzen | |
JP2013126422A (ja) | 加齢黄斑変性症の発症リスクの予測方法 | |
EP2062984A3 (de) | Primer und Sonden zum Nachweis genitaler HPV-Genotypen | |
WO2003020120A3 (en) | Diagnosis and treatment of vascular disease | |
WO2002053018A3 (en) | Method of detecting polymorphisms associated with breast carcinoma in mhc genes | |
WO2003007801A3 (en) | Diagnosis and treatment of vascular disease | |
WO2001018240A3 (en) | Diagnostic and therapeutic methods in autoimmune disease | |
ATE407145T1 (de) | Analyse und verwendung von par 1 polymorphismen zur risikoabschätzung für kardiovaskuläre erkrankungen | |
DE69834831D1 (de) | Gen, das im zusammenhang steht mit gemütskrankheiten |